Macular pigment: From discovery to function

John T. Landrum, Richard A. Bone, Martha Neuringer, Yisi Cao

    Research output: Chapter in Book/Report/Conference proceedingChapter

    2 Citations (Scopus)

    Abstract

    An awareness of the presence of the “macula lutea” dates to a time during the last two decades of the eighteenth century, something more than two centuries ago (Nussbaum et al. 1981; Whitehead et al. 2006). Perhaps, it should be a surprise that fundamental facts needed to describe the macular pigments awaited discovery until the end of the twentieth century (Landrum and Bone 2001). A firm determination of the identities of the macular carotenoids, lutein and zeaxanthin, was established and confirmed during the mid-1980s providing the firm standing essential for further detailed research (Bone et al. 1985, 1988; Handelman et al. 1988). Since that time, the level of interest and enthusiasm that researchers have shown in the macular pigment has grown dramatically. The burgeoning enthusiasm underlying current research into the functional role of the macular pigments is also paralleled by an increasing interest that is now being devoted to the role of other non-vitamin A carotenoids. Bone et al. (1993) demonstrated that the rarely encountered carotenoid, mesozeaxanthin, comprises approximately 30% of the total macular pigment within the central fovea. The ability of carotenoids to act as antioxidants within the body is now widely recognized, and it is accepted that the retina is subject to high oxidative loads (Landrum 2013). The Age-Related Eye Disease Study I (AREDS I) demonstrated that antioxidant consumption significantly retards the progression of early stages of age-related macular degeneration (AMD) and the development of wet neovascular AMD (SanGiovanni et al. 2007). The possibility that the macular pigment has a role in the preservation of central vision among the increasing population of seniors is ample motivation for the intense scrutiny to which the macular carotenoids are now subject. In the United States, the Age-Related Eye Disease Study II (AREDS II), in which lutein and zeaxanthin are specific components, is approaching conclusion and continued research on the transport, localization, and actions of the carotenoids into the macula is certain to remain an important and productive line of investigation for the foreseeable future (Chew et al. 2012). The potentially broad importance of the non-provitamin A carotenoids in maintaining optimal human health also beckons researchers who are investigating the actions and role of carotenoids and their metabolites in cell functions.

    Original languageEnglish (US)
    Title of host publicationCarotenoids and Retinal Disease
    PublisherCRC Press
    Pages1-22
    Number of pages22
    ISBN (Electronic)9781466502055
    ISBN (Print)9781466502048
    DOIs
    StatePublished - Jan 1 2013

    Fingerprint

    Carotenoids
    Lutein
    Bone
    Eye Diseases
    Macular Degeneration
    Bone and Bones
    Macula Lutea
    Antioxidants
    Research
    Research Personnel
    Aptitude
    Macular Pigment
    Metabolites
    Retina
    Motivation
    Health
    Population

    ASJC Scopus subject areas

    • Medicine(all)
    • Biochemistry, Genetics and Molecular Biology(all)
    • Neuroscience(all)
    • Chemistry(all)

    Cite this

    Landrum, J. T., Bone, R. A., Neuringer, M., & Cao, Y. (2013). Macular pigment: From discovery to function. In Carotenoids and Retinal Disease (pp. 1-22). CRC Press. https://doi.org/10.1201/b15556

    Macular pigment : From discovery to function. / Landrum, John T.; Bone, Richard A.; Neuringer, Martha; Cao, Yisi.

    Carotenoids and Retinal Disease. CRC Press, 2013. p. 1-22.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Landrum, JT, Bone, RA, Neuringer, M & Cao, Y 2013, Macular pigment: From discovery to function. in Carotenoids and Retinal Disease. CRC Press, pp. 1-22. https://doi.org/10.1201/b15556
    Landrum JT, Bone RA, Neuringer M, Cao Y. Macular pigment: From discovery to function. In Carotenoids and Retinal Disease. CRC Press. 2013. p. 1-22 https://doi.org/10.1201/b15556
    Landrum, John T. ; Bone, Richard A. ; Neuringer, Martha ; Cao, Yisi. / Macular pigment : From discovery to function. Carotenoids and Retinal Disease. CRC Press, 2013. pp. 1-22
    @inbook{5bdddd5714484888a4352a00331b4585,
    title = "Macular pigment: From discovery to function",
    abstract = "An awareness of the presence of the “macula lutea” dates to a time during the last two decades of the eighteenth century, something more than two centuries ago (Nussbaum et al. 1981; Whitehead et al. 2006). Perhaps, it should be a surprise that fundamental facts needed to describe the macular pigments awaited discovery until the end of the twentieth century (Landrum and Bone 2001). A firm determination of the identities of the macular carotenoids, lutein and zeaxanthin, was established and confirmed during the mid-1980s providing the firm standing essential for further detailed research (Bone et al. 1985, 1988; Handelman et al. 1988). Since that time, the level of interest and enthusiasm that researchers have shown in the macular pigment has grown dramatically. The burgeoning enthusiasm underlying current research into the functional role of the macular pigments is also paralleled by an increasing interest that is now being devoted to the role of other non-vitamin A carotenoids. Bone et al. (1993) demonstrated that the rarely encountered carotenoid, mesozeaxanthin, comprises approximately 30{\%} of the total macular pigment within the central fovea. The ability of carotenoids to act as antioxidants within the body is now widely recognized, and it is accepted that the retina is subject to high oxidative loads (Landrum 2013). The Age-Related Eye Disease Study I (AREDS I) demonstrated that antioxidant consumption significantly retards the progression of early stages of age-related macular degeneration (AMD) and the development of wet neovascular AMD (SanGiovanni et al. 2007). The possibility that the macular pigment has a role in the preservation of central vision among the increasing population of seniors is ample motivation for the intense scrutiny to which the macular carotenoids are now subject. In the United States, the Age-Related Eye Disease Study II (AREDS II), in which lutein and zeaxanthin are specific components, is approaching conclusion and continued research on the transport, localization, and actions of the carotenoids into the macula is certain to remain an important and productive line of investigation for the foreseeable future (Chew et al. 2012). The potentially broad importance of the non-provitamin A carotenoids in maintaining optimal human health also beckons researchers who are investigating the actions and role of carotenoids and their metabolites in cell functions.",
    author = "Landrum, {John T.} and Bone, {Richard A.} and Martha Neuringer and Yisi Cao",
    year = "2013",
    month = "1",
    day = "1",
    doi = "10.1201/b15556",
    language = "English (US)",
    isbn = "9781466502048",
    pages = "1--22",
    booktitle = "Carotenoids and Retinal Disease",
    publisher = "CRC Press",

    }

    TY - CHAP

    T1 - Macular pigment

    T2 - From discovery to function

    AU - Landrum, John T.

    AU - Bone, Richard A.

    AU - Neuringer, Martha

    AU - Cao, Yisi

    PY - 2013/1/1

    Y1 - 2013/1/1

    N2 - An awareness of the presence of the “macula lutea” dates to a time during the last two decades of the eighteenth century, something more than two centuries ago (Nussbaum et al. 1981; Whitehead et al. 2006). Perhaps, it should be a surprise that fundamental facts needed to describe the macular pigments awaited discovery until the end of the twentieth century (Landrum and Bone 2001). A firm determination of the identities of the macular carotenoids, lutein and zeaxanthin, was established and confirmed during the mid-1980s providing the firm standing essential for further detailed research (Bone et al. 1985, 1988; Handelman et al. 1988). Since that time, the level of interest and enthusiasm that researchers have shown in the macular pigment has grown dramatically. The burgeoning enthusiasm underlying current research into the functional role of the macular pigments is also paralleled by an increasing interest that is now being devoted to the role of other non-vitamin A carotenoids. Bone et al. (1993) demonstrated that the rarely encountered carotenoid, mesozeaxanthin, comprises approximately 30% of the total macular pigment within the central fovea. The ability of carotenoids to act as antioxidants within the body is now widely recognized, and it is accepted that the retina is subject to high oxidative loads (Landrum 2013). The Age-Related Eye Disease Study I (AREDS I) demonstrated that antioxidant consumption significantly retards the progression of early stages of age-related macular degeneration (AMD) and the development of wet neovascular AMD (SanGiovanni et al. 2007). The possibility that the macular pigment has a role in the preservation of central vision among the increasing population of seniors is ample motivation for the intense scrutiny to which the macular carotenoids are now subject. In the United States, the Age-Related Eye Disease Study II (AREDS II), in which lutein and zeaxanthin are specific components, is approaching conclusion and continued research on the transport, localization, and actions of the carotenoids into the macula is certain to remain an important and productive line of investigation for the foreseeable future (Chew et al. 2012). The potentially broad importance of the non-provitamin A carotenoids in maintaining optimal human health also beckons researchers who are investigating the actions and role of carotenoids and their metabolites in cell functions.

    AB - An awareness of the presence of the “macula lutea” dates to a time during the last two decades of the eighteenth century, something more than two centuries ago (Nussbaum et al. 1981; Whitehead et al. 2006). Perhaps, it should be a surprise that fundamental facts needed to describe the macular pigments awaited discovery until the end of the twentieth century (Landrum and Bone 2001). A firm determination of the identities of the macular carotenoids, lutein and zeaxanthin, was established and confirmed during the mid-1980s providing the firm standing essential for further detailed research (Bone et al. 1985, 1988; Handelman et al. 1988). Since that time, the level of interest and enthusiasm that researchers have shown in the macular pigment has grown dramatically. The burgeoning enthusiasm underlying current research into the functional role of the macular pigments is also paralleled by an increasing interest that is now being devoted to the role of other non-vitamin A carotenoids. Bone et al. (1993) demonstrated that the rarely encountered carotenoid, mesozeaxanthin, comprises approximately 30% of the total macular pigment within the central fovea. The ability of carotenoids to act as antioxidants within the body is now widely recognized, and it is accepted that the retina is subject to high oxidative loads (Landrum 2013). The Age-Related Eye Disease Study I (AREDS I) demonstrated that antioxidant consumption significantly retards the progression of early stages of age-related macular degeneration (AMD) and the development of wet neovascular AMD (SanGiovanni et al. 2007). The possibility that the macular pigment has a role in the preservation of central vision among the increasing population of seniors is ample motivation for the intense scrutiny to which the macular carotenoids are now subject. In the United States, the Age-Related Eye Disease Study II (AREDS II), in which lutein and zeaxanthin are specific components, is approaching conclusion and continued research on the transport, localization, and actions of the carotenoids into the macula is certain to remain an important and productive line of investigation for the foreseeable future (Chew et al. 2012). The potentially broad importance of the non-provitamin A carotenoids in maintaining optimal human health also beckons researchers who are investigating the actions and role of carotenoids and their metabolites in cell functions.

    UR - http://www.scopus.com/inward/record.url?scp=84978968339&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84978968339&partnerID=8YFLogxK

    U2 - 10.1201/b15556

    DO - 10.1201/b15556

    M3 - Chapter

    AN - SCOPUS:84978968339

    SN - 9781466502048

    SP - 1

    EP - 22

    BT - Carotenoids and Retinal Disease

    PB - CRC Press

    ER -